Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ea9fa1e-2d6d-4fe5-a3af-9c6c3a011f8a
Date 4/1/2015
Company Name aTyr Pharma
Mailing Address 3565 General Atomics Court San Diego, CA 92121 USA
Company Description We have developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts.
Proceeds Purposes The Company plans to use the proceeds to further develop its pipeline and advance its lead program through clinical trials, including an ongoing Phase 1b/2 trial of Resolaris, an investigational new drug representing aTyr’s first Physiocrine-based product candidate in the clinic.